Quick Answer
Voyager Therapeutics, Inc. reported Shares Outstanding of 59.05 million shares for fiscal year 2025.
Voyager Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 59.05M | +7.9% |
| 2024 | 54.73M | +24.3% |
| 2023 | 44.04M | +14.0% |
| 2022 | 38.61M | +1.8% |
| 2021 | 37.92M | +1.5% |
| 2020 | 37.37M | +1.4% |
| 2019 | 36.87M | +13.9% |
| 2018 | 32.36M | +2.5% |
| 2017 | 31.57M | +23.3% |
| 2016 | 25.60M | +2.7% |
| 2015 | 24.93M | +2959.6% |
| 2014 | 814,834 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 55.48M | +1.7% | +0.1% |
| June 30, 2025 | 55.43M | +1.8% | +0.4% |
| March 31, 2025 | 55.21M | +1.6% | +0.9% |
| December 31, 2024 | 54.73M | +24.3% | +0.3% |
| September 30, 2024 | 54.54M | +24.2% | +0.1% |
| June 30, 2024 | 54.47M | +24.5% | +0.3% |
| March 31, 2024 | 54.32M | +25.1% | +23.3% |
| December 31, 2023 | 44.04M | +14.0% | +0.3% |
- Voyager Therapeutics, Inc. showed an increase of +7.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Voyager Therapeutics, Inc.’s shares outstanding has grown by 7146.6% (from 814.8 thousand shares to 59.05 million shares).
- The most recent figure is from Voyager Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: